AGPSMP Pediatric Diseases South Park OOD
- Address
- 110, Dimitar Hadjikotzev str., 1421 Sofia, Bulgaria
AGPSMP Pediatric Diseases South Park OOD
AGPSMP Pediatric Diseases South Park OOD is a specialized clinical research facility focused on acute and chronic respiratory conditions affecting pediatric and general patient populations. The center demonstrates expertise in conducting rigorous controlled trials evaluating novel therapeutic approaches and drug delivery systems for respiratory diseases.
- Asthma management and rescue medication optimization
- Influenza treatment and antiviral resistance surveillance
- Respiratory infection transmission dynamics
The research center conducts comprehensive studies examining both asthma exacerbation prevention through advanced inhaler technologies and influenza viral resistance patterns in real-world settings. Their work includes active surveillance protocols and household transmission studies, contributing valuable data on treatment-emergent resistance mechanisms and optimal therapeutic strategies for respiratory infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1F. Hoffmann-La Roche AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in AGPSMP Pediatric Diseases South Park OOD
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Baloxavir Marboxil Susceptibility in Pediatric Patients with Influenza: A Phase IIIb Multicenter, Single-Arm, Open-Label Study | F. Hoffmann-La Roche AG | Phase III | Recruiting | Nov 2023 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baloxavir Marboxil | 1 | Unknown | 2023-11-24 | 2023-11-24 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.